MaxCyte launches CHANGE-seq-BE and ONE-seq-BE assays
MaxCyte (NASDAQ: MXCT) announces the launch of CHANGE-seq-BE and ONE-seq-BE off-target nomination assays through its SeQure service for adenine and cytosine base editors.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.